T1	Participants 107 143	in patients undergoing chemotherapy.
T2	Participants 302 335	patients undergoing chemotherapy.
T3	Participants 378 411	patients undergoing chemotherapy.
T4	Participants 1103 1136	patients undergoing chemotherapy.
